An2 Therapeutics, INC. (ANTX) SEC Filings — 2025
9 SEC filings for An2 Therapeutics, INC. (ANTX) in 2025.
Filings
- ANTX Narrows Q3 Loss, R&D Spend Halved Amid Cash Burn — 10-Q · Nov 12, 2025
- ANTX Narrows Losses Amid Sharp R&D Spending Cut — 10-Q · Aug 12, 2025
- AN2 Therapeutics Reports Unregistered Equity Sales — 8-K · Jun 20, 2025
- An2 Therapeutics, INC. 8-K Filing — 8-K · Jun 11, 2025
- AN2 Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · May 27, 2025
- AN2 Therapeutics Files Q1 2025 10-Q — 10-Q · May 13, 2025
- AN2 Therapeutics Files 8-K Report — 8-K · May 1, 2025
- AN2 Therapeutics Files 2025 Proxy Statement — DEF 14A · Apr 10, 2025
- AN2 Therapeutics Files 8-K on Operations & Financials — 8-K · Mar 25, 2025